http://orcid.org/0000-0003-0841-004X
References
- O’Hara MW, Swain AM. Rates and risk of postpartum depression: a meta analysis. Int Rev Psychiatry. 1996;8:37–54. doi: 10.3109/09540269609037816
- O’Hara MW, McCabe JE. Postpartum depression: current status and future directions. Annu Rev Clin Psychol. 2013;9:379–407. doi: 10.1146/annurev-clinpsy-050212-185612
- Schiller CE, Meltzer-Brody S, Rubinow DR. The role of reproductive hormones in postpartum depression. CNS Spectr. 2015;20:48–59. doi: 10.1017/S1092852914000480
- Wisner KL, Stowe ZN. Psychobiology of postpartum mood disorders. Semin Reprod Endocrinol. 1997;15:77–89. doi: 10.1055/s-2008-1067970
- Swendsen JD, Mazure CM. Life stress as a risk factor for postpartum depression: current research and methodological issues. Clin Psychol Sci Pract. 2000;7:17–31. doi: 10.1093/clipsy.7.1.17
- Mayberg HS, Liotti M, Brannan SK, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry. 1999;156:675–682.
- Kose S, George MS. Functional magnetic resonance imaging investigations in mood disorders. In: Soares JC, ed. Brain imaging in affective disorders. New York (NY): Marcel Decker, Inc., 2003. p. 119–157.
- Lorberbaum JP, Newman JD, Horwitz AR, et al. A potential role for thalamocingulate circuitry in human maternal behavior. Biol Psychiatry Cogn Neurosci Neuroimaging. 2002;51:431–445.
- Stowe ZN, Casarella J, Landry J, et al. Sertraline in the treatment of women with postpartum major depression. Depression. 1995;3:49–55. doi: 10.1002/depr.3050030109
- Cohen LS, Viguera AC, Bouffard SM, et al. Venlafaxine in the treatment of postpartum depression. J Clin Psychiatry. 2001;62:592–596. doi: 10.4088/JCP.v62n0803
- Wisner KL, Peindl KS, Gigliotti TV. Tricyclics vs SSRIs for postpartum depression. Arch Womens Ment Health. 1999;1:189–191. doi: 10.1007/s007370050027
- Gregoire AJP, Kumar R, Everitt B, et al. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 1996;347:930–933. doi: 10.1016/S0140-6736(96)91414-2
- Zorumski CF, Paul SM, Izumi Y, et al. Neurosteroids, stress and depression: potential therapeutic opportunities. Neurosci Biobehav Rev. 2013;37:109–122. doi: 10.1016/j.neubiorev.2012.10.005
- Paoletti AM, Romagnino S, Contu R, et al. Observational study on the stability of the psychological status during normal pregnancy and increased blood levels of neuroactive steroids with GABA-A receptor agonist activity. Psychoneuroendocrinology. 2006;31:485–492. doi: 10.1016/j.psyneuen.2005.11.006
- Kanes S, Colquhoun H, Gunduz-Bruce H, et al. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Lancet. 2017 Jul 29;390(10093):480–489. doi: 10.1016/S0140-6736(17)31264-3